Maxim Group analyst Jason McCarthy assigned a Buy rating to Actinium Pharmaceuticals (ATNM – Research Report) yesterday and set a
Tag: Jason McCarthy
Maxim Group Gives a Buy Rating to NLS Pharmaceutics (NLSP)
Maxim Group analyst Jason McCarthy assigned a Buy rating to NLS Pharmaceutics (NLSP – Research Report) yesterday and set a
Inmune Bio (INMB) Receives a Buy from Maxim Group
In a report released yesterday, Jason McCarthy from Maxim Group initiated coverage with a Buy rating on Inmune Bio (INMB
Maxim Group Remains a Buy on Field Trip Health (FTRP)
In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Field Trip Health (FTRP –
Maxim Group Thinks Appili Therapeutics Inc Class A’s Stock is Going to Recover
Maxim Group analyst Jason McCarthy maintained a Buy rating on Appili Therapeutics Inc Class A (APLIF – Research Report) on
Cellectar Biosciences (CLRB) Receives a Buy from Maxim Group
Maxim Group analyst Jason McCarthy maintained a Buy rating on Cellectar Biosciences (CLRB – Research Report) on August 27 and
Maxim Group Thinks CNS Pharmaceuticals’ Stock is Going to Recover
Maxim Group analyst Jason McCarthy maintained a Buy rating on CNS Pharmaceuticals (CNSP – Research Report) on August 27 and